Science Translational Medicine · 2025 · 10 citations · 26 references
Life SciencesGeneticsImmunologyInnate ImmunityKidney TransplantationTransplant ImmunologyAcute RejectionAllograft RejectionHistocompatibilityHistocompatibility AntigensMajor Histocompatibility ComplexTransplant RejectionChronic Allograft InjuryClass I Histocompatibility AntigensDonor HistocompatibilityDonor-recipient MismatchDonor-recipient PairingHla Mismatch RecognitionMhc MismatchRenal Transplant Rejection
Donor-recipient mismatches in histocompatibility antigens recognized by lymphoid cells have been demonstrated to adversely affect allograft outcomes. In contrast, it remains unclear whether mismatches sensed by innate myeloid cells have a similar effect. We investigated the consequences of mismatch in the polymorphic gene encoding signal regulatory protein α (SIRPα) on kidney allograft pathology and survival in mice and humans. We found that SIRPα variants elicit monocyte activation by binding to CD47 and that eliminating SIRPα mismatch or recipient CD47 expression prevented chronic allograft pathology in mice receiving major histocompatibility complex (MHC)–mismatched renal allografts. Human genomic analysis identified two haplotype categories, A and B, encoding SIRPα variants with distinct CD47 binding interfaces. In kidney transplant recipients ( N = 455), SIRPα mismatch was associated with increased acute rejection and graft fibrosis in the first posttransplant year, and A recipients of B kidneys had reduced long-term graft survival (hazard ratio, 3.2; 95% confidence interval, 1.5 to 6.9; P = 0.002), a finding that was confirmed in an independent validation cohort ( N = 258). Moreover, monocytes in these graft recipients had an activated phenotype. The effects of SIRPα mismatch were independent of ancestry, human leukocyte antigen mismatch, donor-specific antibodies, and delayed graft function. Therefore, these data demonstrate that a donor-recipient mismatch that causes innate immune activation is a determinant of kidney transplantation outcomes.
26
Erik von Elm, Douglas G. Altman, Matthias Egger et al. · Annals of Internal Medicine · 2007 · 17.2K citations
Public Health, Public Health Practice, Epidemiologic Methods +10
The Natural History of Chronic Allograft Nephropathy
Brian J. Nankivell, Richard Borrows, Caroline Fung et al. · New England Journal of Medicine · 2003 · 1.9K citations · Full text
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Katsuto Takenaka, Tatiana K. Prasolava, Jean Wang et al. · Nature Immunology · 2007 · 494 citations
Life Sciences, Genetics, Hematology +11
Phenotype, function, and differentiation potential of human monocyte subsets
Lisa Boyette, Camila Macedo, Kevin Hadi et al. · PLoS ONE · 2017 · 392 citations · Full text